Bailard’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,300
Closed -$121K 599
2019
Q3
$121K Sell
13,300
-25,000
-65% -$201K 0.01% 513
2019
Q2
$304K Hold
38,300
0.02% 411
2019
Q1
$478K Buy
38,300
+13,300
+53% +$144K 0.03% 305
2018
Q4
$269K Buy
+25,000
New +$292K 0.02% 437

Other funds holding RCUS

Bailard's RCUS Position: Q4 2019 in Review

Bailard sold out of Arcus Biosciences (RCUS) in Q4 2019, closing a stake of 13,300 shares — an estimated $121K sold.

Bailard first reported a position in RCUS in Q4 2018 and held it in 4 quarters. The position peaked at $478K in Q1 2019. 75 funds tracked by Wall St. Rank hold RCUS as of Q4 2019.

  • Bailard reported no remaining Arcus Biosciences position as of Q4 2019 after selling out during the quarter.
  • Bailard sold 13,300 Arcus Biosciences shares in Q4 2019, an estimated $121K.
  • Bailard first reported a position in Arcus Biosciences in Q4 2018 and held it in 4 quarters.
  • Bailard's Arcus Biosciences position peaked at $478K in Q1 2019.
  • 75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2019.

Based on Bailard's 13F filing for Q4 2019, filed 31 Jan 2020.